ImmuMap CEO to participate in the Outsourcing in Clinical Trials Nordics 2019 congress October 22-23 in Copenhagen.
ImmuMap CEO Thomas M. Frøsig will be joining the Outsourcing in Clinical Trials Nordics 2019 congress to meet existing and future clients. Drop a line at firstname.lastname@example.org or call at +45 6178 1882 if you want to meet for a chat about how we can solve your needs.
We are champions in assay development and tailor every study to our customers after a rigorous identification of their individual needs. We offer multicolor flow cytometry, ELISpot, fluorospot, cell culturing and several unique assays taking advance of DNA barcoding of MHC multimers and have experience in both discovery, pre-clinical and clinical phase within cellular immune assays.
We are heading for GCP compliance currently and look forward to being even better suited for taking care of patient sample collection, laboratory studies and data analysis in clinical phase I, II or III trials.